Endo Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO PHARMS, and what generic alternatives to ENDO PHARMS drugs are available?
ENDO PHARMS has eighteen approved drugs.
There are eighteen US patents protecting ENDO PHARMS drugs.
There are two hundred and fifty patent family members on ENDO PHARMS drugs in forty-two countries and three supplementary protection certificates in three countries.
Summary for Endo Pharms
International Patents: | 250 |
US Patents: | 18 |
Tradenames: | 15 |
Ingredients: | 13 |
NDAs: | 18 |
Drugs and US Patents for Endo Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-007 | Feb 29, 2008 | DISCN | Yes | No | 8,808,737 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-002 | Dec 9, 2011 | DISCN | Yes | No | 8,192,722 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-005 | Feb 29, 2008 | DISCN | Yes | No | 8,871,779 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | DISCN | Yes | No | 8,192,722 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | 7,851,482 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Endo Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-006 | Feb 29, 2008 | 8,309,112 | ⤷ Try a Trial |
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-003 | Jun 22, 2006 | 5,128,143 | ⤷ Try a Trial |
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-002 | Jun 22, 2006 | 5,128,143 | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | 5,827,871 | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | 5,464,864 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 5 mg, 10 mg, 20 mg and 40 mg | ➤ Subscribe | 2007-11-23 |
➤ Subscribe | Extended-release Tablets | 30 mg | ➤ Subscribe | 2008-06-12 |
➤ Subscribe | Injection | 250 mg/mL | ➤ Subscribe | 2014-06-11 |
➤ Subscribe | Gel | 10 mg/actuation | ➤ Subscribe | 2012-08-14 |
➤ Subscribe | Extended-release Tablets | 7.5 mg and 15 mg | ➤ Subscribe | 2008-05-29 |
➤ Subscribe | Tablets | 2.5 mg | ➤ Subscribe | 2011-03-09 |
➤ Subscribe | Nasal Spray | 500 mcg/spray | ➤ Subscribe | 2017-04-28 |
International Patents for Endo Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1994034 | ⤷ Try a Trial |
Hungary | E035492 | ⤷ Try a Trial |
Norway | 338235 | ⤷ Try a Trial |
Denmark | 1658054 | ⤷ Try a Trial |
Hong Kong | 1115051 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Endo Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0591280 | C300103 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212 |
0591280 | 01C0019 | France | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212 |
0591280 | SPC/GB03/014 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.